BioXcel Therapeutics Statistics
Total Valuation
BTAI has a market cap or net worth of $42.03 million. The enterprise value is $69.88 million.
Market Cap | 42.03M |
Enterprise Value | 69.88M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BTAI has 37.53 million shares outstanding. The number of shares has increased by 7.87% in one year.
Shares Outstanding | 37.53M |
Shares Change (YoY) | +7.87% |
Shares Change (QoQ) | +4.86% |
Owned by Insiders (%) | 21.77% |
Owned by Institutions (%) | 34.18% |
Float | 25.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 23.94 |
Forward PS | 9.48 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 39.79 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57
Current Ratio | 2.57 |
Quick Ratio | 2.37 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -10.29 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -154.40% |
Return on Capital (ROIC) | -488.69% |
Revenue Per Employee | $23,730 |
Profits Per Employee | -$2.07M |
Employee Count | 74 |
Asset Turnover | 0.02 |
Inventory Turnover | 0.61 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.79% in the last 52 weeks. The beta is 0.36, so BTAI's price volatility has been lower than the market average.
Beta (5Y) | 0.36 |
52-Week Price Change | -85.79% |
50-Day Moving Average | 1.88 |
200-Day Moving Average | 2.83 |
Relative Strength Index (RSI) | 27.10 |
Average Volume (20 Days) | 736,230 |
Short Selling Information
The latest short interest is 1.49 million, so 3.97% of the outstanding shares have been sold short.
Short Interest | 1.49M |
Short Previous Month | 1.48M |
Short % of Shares Out | 3.97% |
Short % of Float | 5.77% |
Short Ratio (days to cover) | 2.48 |
Income Statement
In the last 12 months, BTAI had revenue of $1.76 million and -$153.05 million in losses. Loss per share was -$5.17.
Revenue | 1.76M |
Gross Profit | 424,000 |
Operating Income | -144.75M |
Pretax Income | -153.05M |
Net Income | -153.05M |
EBITDA | -139.18M |
EBIT | -139.50M |
Loss Per Share | -$5.17 |
Balance Sheet
The company has $74.14 million in cash and $101.98 million in debt, giving a net cash position of -$27.84 million or -$0.74 per share.
Cash & Cash Equivalents | 74.14M |
Total Debt | 101.98M |
Net Cash | -27.84M |
Net Cash Per Share | -$0.74 |
Equity (Book Value) | -72.36M |
Book Value Per Share | -1.93 |
Working Capital | 49.44M |
Cash Flow
In the last 12 months, operating cash flow was -$120.36 million and capital expenditures -$20,000, giving a free cash flow of -$120.38 million.
Operating Cash Flow | -120.36M |
Capital Expenditures | -20,000 |
Free Cash Flow | -120.38M |
FCF Per Share | -$3.90 |
Margins
Gross margin is 24.15%, with operating and profit margins of -8,243.11% and -8,715.72%.
Gross Margin | 24.15% |
Operating Margin | -8,243.11% |
Pretax Margin | -8,715.72% |
Profit Margin | -8,715.72% |
EBITDA Margin | -7,925.91% |
EBIT Margin | -7,943.91% |
FCF Margin | -6,855.30% |
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.87% |
Shareholder Yield | -7.87% |
Earnings Yield | -364.10% |
FCF Yield | -286.38% |
Analyst Forecast
The average price target for BTAI is $6.00, which is 435.71% higher than the current price. The consensus rating is "Buy".
Price Target | $6.00 |
Price Target Difference | 435.71% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 139.31% |
EPS Growth Forecast (5Y) | -48.90% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BTAI has an Altman Z-Score of -15.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -15.19 |
Piotroski F-Score | 2 |